International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: Impact of risk factors and treatment modalities on survivorship

In this international multicenter study, we aimed to determine the independent risk factors associated with increased 30 day mortality and the impact of cancer and novel treatment modalities in a large group of patients with and without cancer with COVID-19 from multiple countries. We retrospectivel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:eLife 2023-01, Vol.12
Hauptverfasser: Raad, Issam I, Hachem, Ray, Masayuki, Nigo, Datoguia, Tarcila, Dagher, Hiba, Jiang, Ying, Subbiah, Vivek, Siddiqui, Bilal, Bayle, Arnaud, Somer, Robert, Fernández Cruz, Ana, Gorak, Edward, Bhinder, Arvinder, Mori, Nobuyoshi, Hamerschlak, Nelson, Shelanski, Samuel, Dragovich, Tomislav, Vong Kiat, Yee Elise, Fakhreddine, Suha, Pierre, Abi Hanna, Chemaly, Roy F, Mulanovich, Victor, Adachi, Javier, Borjan, Jovan, Khawaja, Fareed, Granwehr, Bruno, John, Teny, Yepez, Eduardo Yepez, Torres, Harrys A, Ammakkanavar, Natraj Reddy, Yibirin, Marcel, Reyes-Gibby, Cielito C, Pande, Mala, Ali, Noman, Rojo, Raniv Dawey, Ali, Shahnoor M, Deeba, Rita E, Chaftari, Patrick, Matsuo, Takahiro, Ishikawa, Kazuhiro, Hasegawa, Ryo, Aguado-Noya, Ramón, García, Alvaro Garcia, Puchol, Cristina Traseira, Lee, Dong Gun, Slavin, Monica, Teh, Benjamin, Arias, Cesar A, Kontoyiannis, Dimitrios P, Malek, Alexandre E, Chaftari, Anne-Marie
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this international multicenter study, we aimed to determine the independent risk factors associated with increased 30 day mortality and the impact of cancer and novel treatment modalities in a large group of patients with and without cancer with COVID-19 from multiple countries. We retrospectively collected de-identified data on a cohort of patients with and without cancer diagnosed with COVID-19 between January and November 2020 from 16 international centers. We analyzed 3966 COVID-19 confirmed patients, 1115 with cancer and 2851 without cancer patients. Patients with cancer were more likely to be pancytopenic and have a smoking history, pulmonary disorders, hypertension, diabetes mellitus, and corticosteroid use in the preceding 2 wk (p≤0.01). In addition, they were more likely to present with higher inflammatory biomarkers (D-dimer, ferritin, and procalcitonin) but were less likely to present with clinical symptoms (p≤0.01). By country-adjusted multivariable logistic regression analyses, cancer was not found to be an independent risk factor for 30 day mortality (p=0.18), whereas lymphopenia was independently associated with increased mortality in all patients and in patients with cancer. Older age (≥65y) was the strongest predictor of 30 day mortality in all patients (OR = 4.47, p
ISSN:2050-084X
2050-084X
DOI:10.7554/eLife.81127